0001870913-24-000004.txt : 20240123 0001870913-24-000004.hdr.sgml : 20240123 20240123173218 ACCESSION NUMBER: 0001870913-24-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240119 FILED AS OF DATE: 20240123 DATE AS OF CHANGE: 20240123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shanmugam Muthusamy CENTRAL INDEX KEY: 0001870913 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 24553642 MAIL ADDRESS: STREET 1: C/O ANI PHARMACEUTICALS, INC. STREET 2: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 wk-form4_1706049128.xml FORM 4 X0508 4 2024-01-19 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001870913 Shanmugam Muthusamy C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 1 1 0 0 HEAD OF R&D, COO-NOVITIUM OPS 1 Common Stock 47407 D Common Stock 2024-01-19 4 S 0 4524 55.57 D 903312 I Held by Esjay LLC Common Stock 2024-01-22 4 S 0 5692 55.95 D 897620 I Held by Esjay LLC Common Stock 2024-01-23 4 S 0 15000 56.44 D 882620 I Held by Esjay LLC Common Stock 5000 I Held by SS Pharma LLC The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $55.03 to $56.00, inclusive. The reporting person holds voting and dispositive power over the shares held by Esjay LLC. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $55.63 to $56.21, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $56.00 to $57.11, inclusive. The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook 2024-01-23